Identification of Hedgehog pathway components by RNAi in Drosophila cultured cells

Science

Volumn 299, Issue 5615, 2003, Pages 2039-2045

  Lum, Lawrence ^a   Yao, Shenqin ^a   Mozer, Brian ^b   Rovescalli, Alessandra ^b   Von Kessler, Doris ^a   Nirenberg, Marshall ^b   Beachy, Philip A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NIH/NHLBI/LBG   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINS; RNA; TUMORS;

BIOLOGICAL PROCESSES;

GENES;

CASEIN KINASE I; CELL SURFACE PROTEIN; PHOSPHATASE; PHOSPHOTRANSFERASE; RNA;

GENETICS; RNA;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL SURFACE; CONTROLLED STUDY; DROSOPHILA; GENE FUNCTION; GENE IDENTIFICATION; GENE MAPPING; HEDGEHOG; NONHUMAN; PRIORITY JOURNAL; RNA ANALYSIS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

ABNORMALITIES; ANIMALS; CASEIN KINASES; CELLS, CULTURED; COMPUTATIONAL BIOLOGY; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DROSOPHILA; DROSOPHILA PROTEINS; EMBRYO, NONMAMMALIAN; GENE EXPRESSION REGULATION; GENES, INSECT; GENOME; GENOMICS; NEOPLASMS; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTEOGLYCANS; PROTO-ONCOGENE PROTEINS; RNA INTERFERENCE; RNA, DOUBLE-STRANDED; SIGNAL TRANSDUCTION; TRANSFECTION;

ANIMALIA; ERINACEIDAE;

EID: 0037470952     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.1081403     Document Type: Article

References (43)

1. P. W. Ingham, EMBO J. 17, 3505 (1998).
2. J. Taipale, P. A. Beachy, Nature 411, 349 (2001).
3. J. Jiang, G. Struhl, Cell 86, 401 (1996).
4. J. Jia et al., Nature 416, 548 (2002).
5. M. A. Price, D. Kalderon, Cell 108, 823 (2002).
6. C. H. Chen et al., Cell 98, 305 (1999).
7. J. C. Clemens et al., Proc. Natl. Acad. Sci. U.S.A. 97, 6499 (2000).
8. A. Fire et al., Nature 391, 806 (1998).
9. L. Lum et al., data not shown.
10. Materials and methods are available as supporting material on Science Online.
11. In contrast to Ptc inactivation by mutation, dsRNA directed against Ptc does not cause constitutive pathway activation, probably because RNAi-induced loss of ptc mRNA and protein is balanced by a consequent increase in transcription of the still intact ptc gene, resulting in sufficient levels of Ptc protein to maintain pathway regulation. In S2 cells, which lack Ci and consequently this regulatory feedback, Ptc-directed RNAi treatment results in a decrease in Ptc protein and an increase in Smo protein similar to that produced by Hh stimulation (Fig. 1B, inset).
12. T. Preat, Genetics 132, 725 (1992).
13. A. J. Forbes, Y. Nakano, A. M. Taylor, P. W. Ingham, Development (Suppl.) 1993, 115 (1993).
14. M. T. Veemon et al., Curr. Biol., in press.
15. F. van Leeuwen, C. H. Samos, R. Nusse, Nature 368, 342 (1994).
16. D. K. Morrison, M. S. Murakami, V. Cleghon, J. Cell Biol. 150, F57 (2000).
17. G. L. Campbell, A. Tomlinson, Development 127, 4095 (2000).
18. J. J. Lee et al., Science 266, 1528 (1994).
19. I. The, Y. Bellaiche, N. Perrimon, Mol. Cell 4, 633 (1999).
20. Injection of dally dsRNA used in cell-based assays resulted in dramatically weakened or in some cases loss of Wg staining, consistent with the loss of naked cuticle associated with loss of Dally.
21. K. Watanabe, H. Yamada, Y. Yamaguchi, J. Cell. Biol. 130, 1207 (1995).
22. H. H. Song, J. Filmus, Biochim. Biophys. Acta 1573, 241 (2002).
23. Y. Bellaiche, I. The, N. Perrimon, Nature 394, 85 (1998).
24. G. H. Baeg, X. Lin, N. Khare, S. Baumgartner, N. Perrimon, Development 128, 87 (2001).
25. X. Lin, N. Perrimon, Nature 400, 281 (1999).
26. M. Tsuda et al., Nature 400, 276 (1999).
27. Z. Chamoun et al., Science 293, 2080 (2001).
28. J. A. Porter et al., Cell 86, 21 (1996).
29. Of the two dsRNAs targeting CK1α included in the kinase-phosphatase library, only one of these targeting the ORF resulted in a gain in basal reporter activity. The other dsRNA targets the 5′ untranstated region (UTR) and is ineffective, perhaps as a result of possible alternative splicing of the transcript.
30. R. M. McKay, J. M. Peters, J. M. Graff, Dev. Biol. 235, 388 (2001).
31. C. Liu et al., Cell 108, 837 (2002).
32. S. Yanagawa et al., EMBO J. 21, 1733 (2002).
33. J. L. Gomez-Skarmeta, J. Modolell, Genes Dev. 10, 2935 (1996).
34. J. S. Kang et al., EMBO J. 21, 114 (2002).
35. B. De Cat, G. David, Semin. Cell Dev. Biol. 12, 117 (2001).
36. S. Paine-Saunders, B. L. Viviano, S. Saunders, Genomics 57, 455 (1999).
37. S. Brown, J. Russo, D. Chitayat, D. Warburton, Am. J. Hum. Genet. 57, 859 (1995).
38. M. Ramalho-Santos, D. A. Melton, A. P. McMahon, Development 127, 2763 (2000).
39. C. Chiang et al., Nature 383, 407 (1996).
40. S. A. Brown et al., Nature Genet. 20, 180 (1998).
41. F. Cole, R. S. Krauss, Curr. Biol. 13, 411 (2003).
42. N. Denef, D. Neubuser, L. Perez, S. M. Cohen, Cell 102, S21 (2000).
43. We thank A. Kaykas and R. Moon for providing the Super TopFlash reporter; F. Weiss-Garcia and the Sloan-Kettering Hybridoma Core Facility (NY) for development of monoclonal antibodies; R. Gong for technical assistance; S. Celniker for help with annotation of DGCr1; R. L. Johnson and S. M. Cohen for antibodies; S. Zusman at Genetic Services (MA) for help with dally dsRNA embryo injections; and J. Taipale for critical review of the manuscipt. Supported by grants and fellowships from NIH and a Life Sciences Research Foundation Fellowship (L.L.). P.A.B. is an investigator of the Howard Hughes Medical Institute.